Market revenue in 2023 | USD 1,636.2 million |
Market revenue in 2030 | USD 3,010.7 million |
Growth rate | 9.1% (CAGR from 2023 to 2030) |
Largest segment | Pharmaceuticals |
Fastest growing segment | Biologics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biologics, Pharmaceuticals, Medicated Feed Additives |
Key market players worldwide | Zoetis Inc Class A, Boehringer Ingelheim, Merck & Co Inc, Elanco Animal Health Inc, Dechra Pharmaceuticals, Ceva Santé Animale, Phibro Animal Health Corp Class A, Virbac SA, Bimeda Ireland, Biogenesis Bago |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary medicine market will help companies and investors design strategic landscapes.
Pharmaceuticals was the largest segment with a revenue share of 66.28% in 2023. Horizon Databook has segmented the France veterinary medicine market based on biologics, pharmaceuticals, medicated feed additives covering the revenue growth of each sub-segment from 2018 to 2030.
France is renowned for veterinary care. Healthcare provision in the country is divided into two main sectors: companion animals and food-producing animals. Veterinary care & medicine play an important role in maintaining the health & well-being of pets and livestock, particularly in animal disease treatment.
Furthermore, France ranks third after Germany and Russia with regard to the number of companion animals. According to a report published by FEDIAF, 20% of the population in France owns a dog and 29% owns a cat.
Moreover, the presence of key market players, such as Thera Vet, further contributes to the country’s market growth. For instance, in December 2021, Thera Vet announced the launch of BIOCERA-VET in France, Belgium, and the Netherlands.
Horizon Databook provides a detailed overview of country-level data and insights on the France veterinary medicine market , including forecasts for subscribers. This country databook contains high-level insights into France veterinary medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account